Energy shares lead broad rebound on Wall Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Francesca\'s Holdings (FRAN) PT Lowered to $8 at FBR Capital Following 2Q
September 6, 2017 1:40 PM EDTFBR Capital lowered its price target on Francesca\'s Holdings (NASDAQ: FRAN) to $8.00 (from $10.00) while maintaining a Neutral rating following the company's 2Q earnings release. FRAN reported EPS of $0.20, versus the consensus estimate of $0.19. Management guided 3Q17 well below the Street due to... More
Sarepta (SRPT) Could See Exon 53 Approval in 2018, Peak Sales of ~$800M - William Blair
September 6, 2017 11:06 AM EDTWilliam Blair analyst Tim Lugo weighed in on Sarepta Therapeutics (NASDAQ: SRPT) after the company announced positive interim 48-week data from its ongoing European Phase I/II study for DMD patients amenable to skipping exon 53 with golodirsen (SRP-4053).
Lugo notes all... More
UPDATE: Sarepta Therapeutics (SRPT) PT Raised to $55 at Piper Jaffray
September 6, 2017 10:57 AM EDT(Updated - September 6, 2017 11:00 AM EDT)
(updated to add analyst comment)
Piper Jaffray raised its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $55.00 (from $50.00) while maintaining a Overweight rating.
Analyst Edward Tenthoff notes the positive Exon 53 data. The analyst further comments... More
HP Enterprise (HPE) PT Lowered to $14 at Susquehanna Following 3Q
September 6, 2017 8:10 AM EDTSusquehanna lowered its price target on HP Enterprise (NYSE: HPE) to $14.00 (from $17.00) while maintaining a Neutral rating following the company's 3Q earnings report. HPE delivered Jul Q revenues and EPS of $8.2B and $0.30 vs. the consensus of $7.5B/$0.26.
HPE's Oct Q guidance of $0.28 is below... More



